Decay–degradation temporally matched ¹⁷⁷Lu radioactive microspheres for intratumoral combination therapy and transarterial delivery

Transarterial radioembolization (TARE) is an important locoregional treatment for hepatocellular carcinoma (HCC). Herein, biodegradable ¹⁷⁷Lu-HCS-PLGA microspheres with a homogeneous core–shell (HCS) architecture were fabricated via microfluidic double-emulsion technology combined with in situ mineralization and designed for decay–degradation temporal matching. Mean microsphere-associated radioactivity retention remained above 90% through 30 days, while longer-term degradation observations documented progressive carrier erosion and fragmentation. In the H22 subcutaneous tumor model, intratumoral administration of ¹⁷⁷Lu-HCS-PLGA MSs combined with PD-1 blockade was associated with greater tumor growth inhibition and immune-related changes. Transcriptomic analysis and Batf3 -knockout experiments were used to explore the contribution of Batf3 -dependent cDC1s to treatment-associated immune changes. Separately, the beagle renal artery model was used to evaluate catheter delivery and radionuclide retention, whereas the rabbit VX2 orthotopic hepatic tumor model was used to evaluate transarterial delivery, intratumoral retention, and the 14-day local treatment response. These findings provide insights into the design of biodegradable radioactive microspheres for locoregional treatment. Fabrication and experimental evaluation of biodegradable ¹⁷⁷Lu-HCS-PLGA microspheres designed to match carrier degradation with radioactive decay. The schematic summarizes intratumoral treatment with PD-1 blockade in the H22 mouse model and separate transarterial delivery studies in the rabbit VX2 liver tumor and beagle renal artery models

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2026-11-13
DOI
https://doi.org/10.1186/s12951-026-05250-z
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Decay–degradation temporally matched ¹⁷⁷Lu radioactive microspheres for intratumoral combination therapy and transarterial delivery

Guanglin Wang, Jiaxi You, Siping Meng, 梁润波 et al.
2 links
Journal of Nanobiotechnology
Radiopharmaceutical Chemistry and Applications
article

Decay–degradation temporally matched ¹⁷⁷Lu radioactive microspheres for intratumoral combination therapy and transarterial delivery

Guanglin Wang, Jiaxi You, Siping Meng, 梁润波, Xingwei Sun, Qian Huang, Wenjun Liang, Di Wang, Qiang Yuan, Yong Jin
article en

Abstract

Transarterial radioembolization (TARE) is an important locoregional treatment for hepatocellular carcinoma (HCC). Herein, biodegradable ¹⁷⁷Lu-HCS-PLGA microspheres with a homogeneous core–shell (HCS) architecture were fabricated via microfluidic double-emulsion technology combined with in situ mineralization and designed for decay–degradation temporal matching. Mean microsphere-associated radioactivity retention remained above 90% through 30 days, while longer-term degradation observations documented progressive carrier erosion and fragmentation. In the H22 subcutaneous tumor model, intratumoral administration of ¹⁷⁷Lu-HCS-PLGA MSs combined with PD-1 blockade was associated with greater tumor growth inhibition and immune-related changes. Transcriptomic analysis and Batf3 -knockout experiments were used to explore the contribution of Batf3 -dependent cDC1s to treatment-associated immune changes. Separately, the beagle renal artery model was used to evaluate catheter delivery and radionuclide retention, whereas the rabbit VX2 orthotopic hepatic tumor model was used to evaluate transarterial delivery, intratumoral retention, and the 14-day local treatment response. These findings provide insights into the design of biodegradable radioactive microspheres for locoregional treatment. Fabrication and experimental evaluation of biodegradable ¹⁷⁷Lu-HCS-PLGA microspheres designed to match carrier degradation with radioactive decay. The schematic summarizes intratumoral treatment with PD-1 blockade in the H22 mouse model and separate transarterial delivery studies in the rabbit VX2 liver tumor and beagle renal artery models

Journal of Nanobiotechnology
Soochow University (CN), Second Affiliated Hospital of Soochow University (CN)
Good health and well-being
Radiopharmaceutical Chemistry and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon